IDEXX LABORATORIES INC /DE Stock Split Ratio
IDEXX LABORATORIES INC /DE (IDXX) reported Stock Split Ratio of 200.00% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-17.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2018-02-16
- IDEXX LABORATORIES INC /DE stockholders' equity note, stock split, conversion ratio for the quarter ending 2016-03-31 was 200.00%.
- IDEXX LABORATORIES INC /DE stockholders' equity note, stock split, conversion ratio for fiscal 2016 was 200.00%, a 0.00% change from fiscal 2015.
- IDEXX LABORATORIES INC /DE stockholders' equity note, stock split, conversion ratio for fiscal 2015 was 200.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|
| 2016-12-31 | 200.00% 10-K · filed 2017-02-17 | |||
| 2016-09-30 | 200.00% 10-Q · filed 2016-11-01 | |||
| 2016-06-30 | 200.00% 10-Q · filed 2016-08-02 | |||
| 2016-03-31 | 200.00% 10-Q · filed 2016-04-29 | |||
| 2015-12-31 | 200.00% 10-K · filed 2018-02-16 | |||
| 2015-09-30 | 200.00% 10-Q · filed 2015-10-28 | |||
| 2015-06-30 | 200.00% 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |